Speaker illustration

Doctor Krishna Prasad

Medicines and Healthcare Products Regulatory Agency, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

Krishna Prasad is a Group Manager at the UK Regulatory Agency with management responsibility for Cardiovascular- diabetes, anti-infective agents, and oncology therapy areas. Dr Prasad’s additional roles include Cardiology consultancy at St. Thomas’ hospital, London. He has worked for MHRA, the UK regulatory agency since 2002 . Dr Prasad’s areas of special interests include heart failure, sudden death, cardiomyopathies and arrhythmias. He is a member of the Cardiovascular working party since 2008, assuming responsibility for coordinating European guidances on heart failure, lipid modifying agents as well as paediatric guidances in these areas. He is participated in many regulatory-scientific dialogues and has a keen interest in global harmonisation of both clinical trials and regulatory guidances. He has served as the Chair of the Pharmacogenomic working party of EMA. He was the Regulatory chair of the ICH expert groups for E-14 ( QT/QTc) and E-18 Genomic sampling guidelines.

Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session type: Moderated Posters

Thumbnail

This platform is supported by

logo Novo Nordisk